SOAT1 Antibodies

Santa Cruz Biotechnology offers a broad range of SOAT1 monoclonal antibodies for research focused on understanding SOAT1's role in cellular processes. SOAT1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SOAT1, or sterol O-acyltransferase 1, is a key enzyme involved in cholesterol metabolism and lipid homeostasis. SOAT1 plays a crucial role in the esterification of free cholesterol, which is essential for maintaining cellular lipid balance and membrane integrity. Dysregulation of SOAT1 has been implicated in various diseases, including atherosclerosis and neurodegenerative disorders, making it an important target for therapeutic intervention. SOAT1 research continues to reveal new insights into cellular metabolism and disease mechanisms. Ongoing studies highlight SOAT1's significance in maintaining cellular health and homeostasis. Understanding SOAT1's molecular mechanisms can lead to breakthroughs in treating metabolic disorders. Santa Cruz Biotechnology monoclonal antibodies for SOAT1 enable researchers worldwide to advance scientific understanding of cellular metabolism and disease pathways.